Cargando…
Efficacy of φkm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection
PURPOSE: Few effective antibiotics are available for treating extensively drug-resistant Acinetobacter baumannii (XDRAB) sepsis. Phage therapy may show potential in treating XDRAB infections. MATERIALS AND METHODS: We studied φkm18p phage therapy in BALB/c and C57BL/6 mice models of XDRAB bacteremia...
Autores principales: | Wang, Jiun-Ling, Kuo, Chih-Feng, Yeh, Che-Ming, Chen, Jung-Ren, Cheng, Ming-Fang, Hung, Chih-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245353/ https://www.ncbi.nlm.nih.gov/pubmed/30532563 http://dx.doi.org/10.2147/IDR.S179701 |
Ejemplares similares
-
Isolation and Characterization of φkm18p, a Novel Lytic Phage with Therapeutic Potential against Extensively Drug Resistant Acinetobacter baumannii
por: Shen, Gwan-Han, et al.
Publicado: (2012) -
The Tail Associated Protein of Acinetobacter baumannii Phage ΦAB6 Is the Host Specificity Determinant Possessing Exopolysaccharide Depolymerase Activity
por: Lai, Meng-Jiun, et al.
Publicado: (2016) -
Global Transcriptomic Analysis of the Interactions between Phage φAbp1 and Extensively Drug-Resistant Acinetobacter baumannii
por: Yang, Zichen, et al.
Publicado: (2019) -
Phage φAB6-Borne Depolymerase Combats Acinetobacter baumannii Biofilm Formation and Infection
por: Shahed-Al-Mahmud, Md., et al.
Publicado: (2021) -
Potential of bacteriophage ΦAB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii
por: Chen, Li-Kuang, et al.
Publicado: (2013)